Sarepta Therapeutics's market cap is currently $10.36B. The company's EPS TTM is $1.203; its P/E ratio is 90.06; Sarepta Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $1.92. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.24B	$ 933.01M	$ 701.89M	$ 540.10M	$ 380.83M
Gross Profit	$ 1.09B	$ 793.02M	$ 604.84M	$ 476.72M	$ 324.25M
Operating Income	$ -267.82M	$ -536.20M	$ -449.71M	$ -564.16M	$ -522.32M
EBITDA	$ -439.20M	$ -582.12M	$ -306.08M	$ -453.38M	$ -652.66M
Net Income	$ -535.98M	$ -703.49M	$ -418.78M	$ -554.13M	$ -715.08M
Balance Sheet
Cash & Short-Term Investments	$ 1.68B	$ 1.99B	$ 2.12B	$ 1.94B	$ 1.12B
Total Assets	$ 3.26B	$ 3.13B	$ 3.15B	$ 2.98B	$ 1.82B
Total Debt	$ 1.40B	$ 1.62B	$ 1.14B	$ 1.07B	$ 729.62M
Net Debt	$ 968.38M	$ 650.58M	$ -977.48M	$ -429.79M	$ -105.46M
Total Liabilities	$ 2.41B	$ 2.74B	$ 2.22B	$ 2.22B	$ 1.00B
Stockholders' Equity	$ 859.34M	$ 384.95M	$ 928.01M	$ 761.76M	$ 818.19M
Cash Flow
Free Cash Flow	$ -588.34M	$ -356.17M	$ -481.66M	$ 25.26M	$ -519.18M
Operating Cash Flow	$ -500.99M	$ -325.35M	$ -443.17M	$ 107.47M	$ -456.46M
Investing Cash Flow	$ -165.80M	$ -1.05B	$ 495.41M	$ -121.72M	$ 286.73M
Financing Cash Flow	$ 125.00M	$ 232.51M	$ 561.57M	$ 682.32M	$ 642.55M

Currency in USD

Sarepta Therapeutics Earnings and Revenue History

Income Statement >

Sarepta Therapeutics Debt to Assets

Balance Sheet >

Sarepta Therapeutics Cash Flow

Cash Flow >

Sarepta Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing